Cargando…
Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547170/ http://dx.doi.org/10.1186/2051-1426-3-S1-O6 |
_version_ | 1782387050192830464 |
---|---|
author | Page, David B Diab, Adi Yuan, Jianda Dong, Zhiwan Soloman, Stephen B Patil, Sujata Hudis, Clifford A Wolchok, Jedd D Norton, Larry McArthur, Heather L |
author_facet | Page, David B Diab, Adi Yuan, Jianda Dong, Zhiwan Soloman, Stephen B Patil, Sujata Hudis, Clifford A Wolchok, Jedd D Norton, Larry McArthur, Heather L |
author_sort | Page, David B |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4547170 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45471702015-09-10 Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients Page, David B Diab, Adi Yuan, Jianda Dong, Zhiwan Soloman, Stephen B Patil, Sujata Hudis, Clifford A Wolchok, Jedd D Norton, Larry McArthur, Heather L J Immunother Cancer Oral Presentation BioMed Central 2015-08-14 /pmc/articles/PMC4547170/ http://dx.doi.org/10.1186/2051-1426-3-S1-O6 Text en Copyright © 2015 Page et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Oral Presentation Page, David B Diab, Adi Yuan, Jianda Dong, Zhiwan Soloman, Stephen B Patil, Sujata Hudis, Clifford A Wolchok, Jedd D Norton, Larry McArthur, Heather L Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients |
title | Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients |
title_full | Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients |
title_fullStr | Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients |
title_full_unstemmed | Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients |
title_short | Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients |
title_sort | pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (esbc) patients |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547170/ http://dx.doi.org/10.1186/2051-1426-3-S1-O6 |
work_keys_str_mv | AT pagedavidb preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients AT diabadi preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients AT yuanjianda preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients AT dongzhiwan preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients AT solomanstephenb preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients AT patilsujata preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients AT hudisclifforda preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients AT wolchokjeddd preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients AT nortonlarry preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients AT mcarthurheatherl preoperativeimmunotherapywithtumorcryoablationcryoplusipilimumabipiinducespotentiallyfavorablesystemicandintratumoralimmuneeffectsinearlystagebreastcanceresbcpatients |